OPGx-RDH12 / Opus Genetics - LARVOL DELTA

Safety and Tolerability of Subretinal OPGx-RDH12-1001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) (clinicaltrials.gov) - P1/2 | N=10 | Not yet recruiting | Sponsor: Opus Genetics, Inc

New P1/2 trial • Inherited Retinal Dystrophy • Ophthalmology